Leading Women's Health Care Company Leverages Features in Siebel CRM On Demand Life Sciences Edition to Avoid Costly Customization
SAN MATEO, Calif. - June 14, 2005 - Oracle Corporation (NASDAQ: SEBL), the leading provider of customer-facing solutions, today announced that FEI Women's Health, the world's leading marketer of intrauterine contraceptives, chose Siebel CRM On Demand for its hosted CRM solution. Siebel CRM On Demand allowed FEI to quickly market and sell its product through multiple touch-point programs with customers, doctors, hospitals and insurance companies.
As a women's healthcare company specializing in contraception, FEI has dedicated itself to making its product available to women worldwide. As the sole U.S. manufacturer and marketer of the ParaGard? T 380A Intrauterine Copper Contraceptive device, FEI is focused exclusively on supporting the women who use this unique form of birth-control as well as the healthcare professionals and insurance companies who serve them.
"We wanted a single view of the customer across multiple touch points. With its ease of use, the Siebel CRM On Demand Life Sciences edition gave us out-of-the-box support for the complex relationships between doctors, hospitals, practices, clinicians and insurance companies that is simply not available with other hosted solutions or would have required costly customization and time to address through workarounds," said Scott Coleridge, Executive Vice President of Sales, FEI Women's Health. "We chose Oracle Corporation because of its superior reputation, rapid deployment capabilities, limited upfront capital investment and overall reliability."
Siebel CRM On Demand Life Sciences Edition offers an industry-leading medical-specific solution that provides customers with superior business insight to drive increased revenues, productivity and customer satisfaction. Leveraging ten years of proven Life Sciences success with industry-leading companies, Siebel CRM On Demand Life Sciences edition seamlessly incorporates industry-specific best practices, such as Complex Relationships Management, Customer-centric Forecasting and MedEd-driven Influence Selling. The combination of Oracle's CRM expertise and Life Sciences best practices, along with the ease of use of Siebel CRM On Demand enables medical products companies to effectively manage their unique, industry-specific business processes.
"As the head of the department charged with implementing and maintaining the technical aspects of our CRM solution, I was initially very concerned about the time and resources required of this new initiative. In actuality, the Siebel CRM On Demand implementation was a breeze and, in just three months, we have retired a number of other tools while increasing service levels and decreasing overall user support time," said John Joseph, Director, Information Technology, FEI Women's Health. "Furthermore, since initial implementation, subsequent enhancements and new ideas have been developed and rolled out painlessly. It's nice to know that as my company's leadership discovers changes and enhancements to the original vision, my department can handle those requests easily and in a timeframe that exceeds management expectations."
Media Contact:
Stacey Burbach
Oracle Corporation
Tel: (480) 377-3725
Email:
stacey.burbach@siebel.com
Except for the historical information contained herein, this press release contains forward-looking statements that involve risk or uncertainties. Future operating results of Oracle Corporation may differ from the results discussed or forecasted in the forward-looking statements due to factors that include, but are not limited to, risks associated with customer relations, such as the availability of Oracle Corporation' products and services, customer implementation of products and services, relationships with customers, third-party vendors and systems integrators, concentration of revenues in a relatively small number of customers, existence of errors or defects in products, ability to successfully manage growth, significant current and expected additional competition and the need to continue to expand product distribution and services offerings. Further information on potential factors that could affect the financial results of Oracle Corporation are included in Oracle Corporation' Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other filings with the Securities and Exchange Commission, which are available at www.sec.gov. Oracle Corporation assumes no obligation to update the information in this press release.
Oracle is a trademark of Oracle Corporation and may be registered in certain jurisdictions. All other product and firm names mentioned are the property of their respective owners and are mentioned for identification purposes only.